Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2020, to consider the following items of businesses and related matters: to consider Un-audited Financial Results for the quarter ended June 30, 2020; to consider interim dividend, if any for the financial year 2020-21. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Trading window for dealing in the securities of the Company by the Employee(s) / Director(s) and their immediate relatives will be closed from August 04, 2020 to August 14, 2020. Trading window will be opened on August 17, 2020.
The above information is a part of company’s filings submitted to BSE.
